Kesar Biotech Private Limited
About Kesar Biotech Private Limited
Data last updated:
Kesar Biotech Private Limited was a private limited company based in Delhi, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the retail trading segment of the trading and commerce sector. It was incorporated on 23 November 2005.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U73100DL2005PTC142900.
The company had an authorised share capital of ₹35 Lakh and a paid-up capital of ₹31.89 Lakh. It was led by directors Nirmla Gupta and Anand Parkash Gupta.
Its last annual general meeting (AGM) was held on 31 May 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office was at 41 Samrat Enclavepitampura Delhi, Delhi, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹30,000, a decline of 1% compared to the previous year. For the same year it recorded a net loss of ₹22,654 (net margin -75.5%) and EBITDA of -₹17,376 (EBITDA margin -57.9%). Revenue has declined at a compounded annual rate (CAGR) of 42% over three years and 22% over five years.
Company details
Contact details
Kesar Biotech Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address41 Samrat Enclavepitampura Delhi, Delhi, India
- IndustryTrading, Retail Trading, Retailers
To see the full contact details of Kesar Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kesar Biotech is professional, scientific and technical. In detail, this covers management consultancy activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M3 | Management consultancy activities |
To see the full business activity and turnover split of Kesar Biotech Private Limited, buy the company report.
Financials of Kesar Biotech Private Limited
FY 2025 filings availableKesar Biotech Private Limited reported revenue of ₹30,000 (down 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 22% over five years, including a 1% fall in the latest year. EBITDA fell 174% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹17,376 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹22,654 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -57.9% | ||||
| Net Profit Margin | -75.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kesar Biotech Private Limited, buy the company report.
Board of directors of Kesar Biotech Private Limited
Kesar Biotech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nirmla Gupta | Director | 30 Mar 2007 | 19 Years 7 Months | As last reported |
| Anand Parkash Gupta | Director | 23 Nov 2005 | 20 Years 11 Months | As last reported |
Peer comparison
Kesar Biotech Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (management consultancy activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kesar Biotech Private Limitedthis company | ₹30,000 (FY 2025) | -₹22,654 | -75.5% | -1.0% | Delhi, India | |
| Proadroit Advisors Private Limited | ₹30,000 (FY 2025) | -52.0% | New Delhi, Delhi, India | |||
| Bristol Enterprises Private Limited | ₹30,000 (FY 2019) | -40.0% | New Delhi, Delhi, India | |||
| Apurv Services Private Limited | ₹30,000 (FY 2025) | New Delhi, Delhi, India | ||||
| Grnconnect Private Limited | ₹30,000 (FY 2025) | New Delhi, Delhi, India | ||||
| Fa-Infra Investment Management Private Limited | ₹30,000 (FY 2020) | New Delhi, Delhi, India | ||||
| Global Hunt Overseas Private Limited | ₹30,000 (FY 2025) | -14.0% | New Delhi, Delhi, India | |||
| System Application and Compliance Point Private Limited | ₹30,000 (FY 2024) | 159.0% | Thane, Maharashtra, India | |||
| DCPL Enterprises Private Limited | ₹30,000 (FY 2025) | -40.0% | Raipur, Chhattisgarh, India | |||
| Cde Advisory Consulttancy Private Limited | ₹30,000 (FY 2023) | -14.0% | Chennai, Tamil Nadu, India | |||
| Ignite Immigration Private Limited | ₹30,000 (FY 2024) | New Delhi, Delhi, India |
To see the full peer comparison of Kesar Biotech Private Limited, buy the company report.
Auditor
Kesar Biotech Private Limited is audited by Prakash K. Prakash for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Prakash K. Prakash | FY 2017 | 000415N |
Shareholding
The shareholding of Kesar Biotech Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Kesar Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kesar Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kesar Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Kesar Biotech has 1 associated company. This group structure data is as of FY 2017. The table lists each entity with its relationship and holding.
GST
No GST registration is on our record for Kesar Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Kesar Biotech Private Limited has 3 board changes on record since 2005: 2 appointments and 1 cessation. The latest: Karuna Gupta ceased to be Director on 31 Mar 2007.
Frequently asked questions
Kesar Biotech has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Kesar Biotech was a private limited company based in Delhi, India. The company worked in retail trading, within the trading industry. It was incorporated on 23 November 2005 and is registered under CIN U73100DL2005PTC142900. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Kesar Biotech is U73100DL2005PTC142900. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kesar Biotech had 2 directors:
- Nirmla Gupta - Director
- Anand Parkash Gupta - Director
Kesar Biotech was incorporated on 23 November 2005. It is registered with the Registrar of Companies, Delhi.
The registered office of Kesar Biotech is at 41 Samrat Enclavepitampura Delhi, Delhi, India.
The latest financial statements of Kesar Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 May 2025. Year-wise statements from 2015 are in the company report.
Kesar Biotech operated in the trading industry, in the retail trading segment.
The peers of Kesar Biotech by revenue are Proadroit Advisors Private Limited, Bristol Enterprises Private Limited, Apurv Services Private Limited, Grnconnect Private Limited, Fa-Infra Investment Management Private Limited and 5 more, all in the same principal business activity (management consultancy activities).
Karuna Gupta ceased to be Director on 31 Mar 2007. Nirmla Gupta was appointed as Director on 30 Mar 2007. Anand Parkash Gupta was appointed as Director on 23 Nov 2005.
The compliance status of Kesar Biotech is compliant as of 22 July 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
